Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

5-Amino-1MQ vs Retatrutide

5-Amino-1MQ and Retatrutide are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassSmall-molecule NNMT inhibitor (methylquinolinium salt) — not a peptideLipidated single-chain triple receptor agonist (GIP / GLP-1 / glucagon)
Molecular weightNot specified4759.5 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasMetabolic, Cellular LongevityMetabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for several weeks at 2-8 °C in preserved diluent.Commonly worked with for 4–6 weeks at 2–8 °C.
Lead degradation routeMicrobial growth in non-preserved diluent — a container problem rather than a molecular one.Interfacial aggregation from agitation, foaming, or freeze–thaw — the primary practical failure mode for this molecule class.
Freeze–thawTolerant of freeze-thaw — there is no tertiary structure to lose. Aliquoting is still good practice to limit repeated exposure of the stock.Avoid freezing reconstituted material. For lipidated peptides the freeze–thaw risk is aggregation at the ice–liquid interface rather than chemical breakdown, and aggregation is not reversible on rewarming.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: 5-Amino-1MQ is small-molecule nnmt inhibitor (methylquinolinium salt) — not a peptide, while Retatrutide is lipidated single-chain triple receptor agonist (gip / glp-1 / glucagon) — different molecular classes with different handling consequences; their leading degradation routes differ (microbial growth in non-preserved diluent for 5-Amino-1MQ, interfacial aggregation from agitation, foaming, or freeze–thaw for Retatrutide), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

5-Amino-1MQ — origin

5-Amino-1MQ is a small quinolinium molecule characterised as a first-in-class inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme studied at the intersection of adipocyte metabolism and the cellular NAD+/methylation pool. It is not an amino-acid chain, which is why it sits apart from every peptide in this catalogue.

Retatrutide — origin

Retatrutide is a rationally engineered single peptide chain designed to activate three receptors at once — GIP, GLP-1, and glucagon. It represents the third generation of incretin design: mono-agonists first, dual agonists such as tirzepatide second, and triagonists third. Adding glucagon-receptor activity is the conceptual leap, since glucagon signalling contributes energy expenditure rather than only appetite and glycaemic effects.

5-Amino-1MQ research themes

NNMT inhibition

The defining mechanism — preclinical work has examined how blocking NNMT shifts methylation flux and NAD+ salvage in metabolic tissue models.

Adipocyte energy metabolism

Studied in fat-cell models for effects on cellular energy handling and lipid metabolism.

NAD+ economy

Because NNMT consumes a methyl group tied to the NAD+ precursor pool, it is studied alongside the wider NAD+ research field.

Retatrutide research themes

Triple receptor engagement

The defining feature: simultaneous GIP, GLP-1, and glucagon receptor activity from one chain.

Energy expenditure

Glucagon-receptor activity is studied for its contribution to energy expenditure, distinguishing triagonists from dual agonists.

Glucose regulation

Investigated in metabolic research models for effects on glucose homeostasis.

Body composition in research models

A major focus of the preclinical literature on this compound class.

5-Amino-1MQ handling

  • Let the sealed vial reach room temperature before opening so moisture does not condense onto the powder.
  • For cell-based assays, prepare a concentrated DMSO stock and dilute into aqueous buffer rather than dissolving directly at high concentration in medium.
  • Label aliquots with reconstitution date and diluent.

Retatrutide handling

  • Never shake. Foam on a lipidated peptide solution is denatured material at the air–liquid interface, not a cosmetic issue.
  • Introduce diluent slowly down the vial wall and allow the cake to dissolve without agitation, which may take several minutes.
  • Do not freeze reconstituted solution — aggregation from freeze–thaw is irreversible.
  • Faint opalescence at high concentration is expected; visible particulate is not.

Both third-party tested

Every Popular Peptides batch of 5-Amino-1MQ and Retatrutide is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

5-Amino-1MQ reference

Full 5-Amino-1MQ reference 5-Amino-1MQ storage 5-Amino-1MQ reconstitution 5-Amino-1MQ calculator5-Amino-1MQ product details

Retatrutide reference

Full Retatrutide reference Retatrutide storage Retatrutide reconstitution Retatrutide calculatorRetatrutide product details

Related comparisons

5-Amino-1MQ vs CJC-1295 (No DAC)5-Amino-1MQ vs CJC-1295 + Ipamorelin5-Amino-1MQ vs DSIP5-Amino-1MQ vs Epitalon5-Amino-1MQ vs GLOW5-Amino-1MQ vs IGF-15-Amino-1MQ vs IGF-1 LR35-Amino-1MQ vs Ipamorelin

5-Amino-1MQ and Retatrutide are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.